nodes	percent_of_prediction	percent_of_DWPC	metapath
Rivastigmine—Sick sinus syndrome—Thalidomide—leprosy	0.0359	0.0383	CcSEcCtD
Rivastigmine—Emphysema—Thalidomide—leprosy	0.0359	0.0383	CcSEcCtD
Rivastigmine—Application site burn—Dapsone—leprosy	0.0351	0.0375	CcSEcCtD
Rivastigmine—CYP3A4—Rifampicin—leprosy	0.0347	0.548	CbGbCtD
Rivastigmine—Application site erythema—Dapsone—leprosy	0.0312	0.0333	CcSEcCtD
Rivastigmine—Application site pruritus—Dapsone—leprosy	0.0301	0.0321	CcSEcCtD
Rivastigmine—CYP3A4—Dapsone—leprosy	0.0286	0.452	CbGbCtD
Rivastigmine—Parkinson's disease—Thalidomide—leprosy	0.0259	0.0277	CcSEcCtD
Rivastigmine—Anxiety depression—Thalidomide—leprosy	0.0229	0.0245	CcSEcCtD
Rivastigmine—Application site pain—Dapsone—leprosy	0.0167	0.0178	CcSEcCtD
Rivastigmine—Peritonitis—Thalidomide—leprosy	0.0149	0.0159	CcSEcCtD
Rivastigmine—Suicide attempt—Dapsone—leprosy	0.013	0.0138	CcSEcCtD
Rivastigmine—Lipase increased—Thalidomide—leprosy	0.0128	0.0137	CcSEcCtD
Rivastigmine—Pyuria—Thalidomide—leprosy	0.0108	0.0115	CcSEcCtD
Rivastigmine—Albuminuria—Dapsone—leprosy	0.00985	0.0105	CcSEcCtD
Rivastigmine—Hypochromic anaemia—Thalidomide—leprosy	0.00971	0.0104	CcSEcCtD
Rivastigmine—Dementia—Thalidomide—leprosy	0.00917	0.00979	CcSEcCtD
Rivastigmine—Lacrimal disorder—Thalidomide—leprosy	0.00842	0.00898	CcSEcCtD
Rivastigmine—Hyporeflexia—Thalidomide—leprosy	0.00828	0.00884	CcSEcCtD
Rivastigmine—Parkinsonism—Thalidomide—leprosy	0.00828	0.00884	CcSEcCtD
Rivastigmine—Raised liver function tests—Thalidomide—leprosy	0.00815	0.0087	CcSEcCtD
Rivastigmine—Hernia—Thalidomide—leprosy	0.00803	0.00857	CcSEcCtD
Rivastigmine—Transient ischaemic attack—Thalidomide—leprosy	0.00746	0.00796	CcSEcCtD
Rivastigmine—Skin exfoliation—Dapsone—leprosy	0.00702	0.00749	CcSEcCtD
Rivastigmine—Suicide attempt—Thalidomide—leprosy	0.00663	0.00708	CcSEcCtD
Rivastigmine—Gastric ulcer—Thalidomide—leprosy	0.00648	0.00691	CcSEcCtD
Rivastigmine—Hypothyroidism—Thalidomide—leprosy	0.00586	0.00626	CcSEcCtD
Rivastigmine—Tooth disorder—Thalidomide—leprosy	0.0058	0.00619	CcSEcCtD
Rivastigmine—Nail disorder—Thalidomide—leprosy	0.0058	0.00619	CcSEcCtD
Rivastigmine—Intestinal obstruction—Thalidomide—leprosy	0.00552	0.00589	CcSEcCtD
Rivastigmine—Seborrhoeic dermatitis—Thalidomide—leprosy	0.00552	0.00589	CcSEcCtD
Rivastigmine—Neuralgia—Thalidomide—leprosy	0.00542	0.00578	CcSEcCtD
Rivastigmine—Lung disorder—Thalidomide—leprosy	0.00532	0.00568	CcSEcCtD
Rivastigmine—Thrombosis—Thalidomide—leprosy	0.00532	0.00568	CcSEcCtD
Rivastigmine—Metrorrhagia—Thalidomide—leprosy	0.00527	0.00562	CcSEcCtD
Rivastigmine—Nystagmus—Thalidomide—leprosy	0.00527	0.00562	CcSEcCtD
Rivastigmine—Hyperlipidaemia—Thalidomide—leprosy	0.00522	0.00557	CcSEcCtD
Rivastigmine—Psychotic disorder—Dapsone—leprosy	0.00521	0.00556	CcSEcCtD
Rivastigmine—Albuminuria—Thalidomide—leprosy	0.00504	0.00538	CcSEcCtD
Rivastigmine—Pleural effusion—Thalidomide—leprosy	0.00491	0.00525	CcSEcCtD
Rivastigmine—Skin ulcer—Thalidomide—leprosy	0.00483	0.00516	CcSEcCtD
Rivastigmine—Nasopharyngitis—Dapsone—leprosy	0.00477	0.00509	CcSEcCtD
Rivastigmine—Muscular weakness—Dapsone—leprosy	0.00471	0.00502	CcSEcCtD
Rivastigmine—Myocardial ischaemia—Thalidomide—leprosy	0.00468	0.005	CcSEcCtD
Rivastigmine—Pancreatitis—Dapsone—leprosy	0.00452	0.00483	CcSEcCtD
Rivastigmine—Apnoea—Thalidomide—leprosy	0.00444	0.00474	CcSEcCtD
Rivastigmine—Photosensitivity reaction—Dapsone—leprosy	0.00421	0.00449	CcSEcCtD
Rivastigmine—Musculoskeletal stiffness—Thalidomide—leprosy	0.0042	0.00448	CcSEcCtD
Rivastigmine—Viral infection—Thalidomide—leprosy	0.00417	0.00445	CcSEcCtD
Rivastigmine—Skin discolouration—Thalidomide—leprosy	0.00417	0.00445	CcSEcCtD
Rivastigmine—Bone disorder—Thalidomide—leprosy	0.00417	0.00445	CcSEcCtD
Rivastigmine—Arthropathy—Thalidomide—leprosy	0.00414	0.00442	CcSEcCtD
Rivastigmine—Cellulitis—Thalidomide—leprosy	0.00414	0.00442	CcSEcCtD
Rivastigmine—Oliguria—Thalidomide—leprosy	0.00408	0.00436	CcSEcCtD
Rivastigmine—Herpes simplex—Thalidomide—leprosy	0.00408	0.00436	CcSEcCtD
Rivastigmine—Neuropathy peripheral—Dapsone—leprosy	0.00403	0.0043	CcSEcCtD
Rivastigmine—Dyskinesia—Thalidomide—leprosy	0.004	0.00427	CcSEcCtD
Rivastigmine—Leukocytosis—Thalidomide—leprosy	0.004	0.00427	CcSEcCtD
Rivastigmine—Hypercholesterolaemia—Thalidomide—leprosy	0.00398	0.00425	CcSEcCtD
Rivastigmine—Bone pain—Thalidomide—leprosy	0.00393	0.00419	CcSEcCtD
Rivastigmine—Atrioventricular block—Thalidomide—leprosy	0.00388	0.00414	CcSEcCtD
Rivastigmine—Sinusitis—Dapsone—leprosy	0.00386	0.00412	CcSEcCtD
Rivastigmine—Gait disturbance—Thalidomide—leprosy	0.00386	0.00412	CcSEcCtD
Rivastigmine—Coordination abnormal—Thalidomide—leprosy	0.00383	0.00409	CcSEcCtD
Rivastigmine—Phosphatase alkaline increased—Thalidomide—leprosy	0.00376	0.00402	CcSEcCtD
Rivastigmine—Pulmonary embolism—Thalidomide—leprosy	0.00376	0.00402	CcSEcCtD
Rivastigmine—Eructation—Thalidomide—leprosy	0.0037	0.00395	CcSEcCtD
Rivastigmine—Pharyngitis—Dapsone—leprosy	0.00366	0.00391	CcSEcCtD
Rivastigmine—Colitis—Thalidomide—leprosy	0.00361	0.00386	CcSEcCtD
Rivastigmine—Candida infection—Thalidomide—leprosy	0.00359	0.00384	CcSEcCtD
Rivastigmine—Skin exfoliation—Thalidomide—leprosy	0.00359	0.00384	CcSEcCtD
Rivastigmine—Neuropathy—Thalidomide—leprosy	0.00353	0.00377	CcSEcCtD
Rivastigmine—Cramps of lower extremities—Thalidomide—leprosy	0.00346	0.00369	CcSEcCtD
Rivastigmine—Tinnitus—Dapsone—leprosy	0.00344	0.00367	CcSEcCtD
Rivastigmine—Oesophagitis—Thalidomide—leprosy	0.00344	0.00367	CcSEcCtD
Rivastigmine—Rash maculo-papular—Thalidomide—leprosy	0.00342	0.00365	CcSEcCtD
Rivastigmine—Pulmonary oedema—Thalidomide—leprosy	0.00335	0.00358	CcSEcCtD
Rivastigmine—Hypertonia—Thalidomide—leprosy	0.0033	0.00352	CcSEcCtD
Rivastigmine—Hyperkinesia—Thalidomide—leprosy	0.00328	0.0035	CcSEcCtD
Rivastigmine—Mental disability—Thalidomide—leprosy	0.00327	0.00349	CcSEcCtD
Rivastigmine—Sepsis—Thalidomide—leprosy	0.00327	0.00349	CcSEcCtD
Rivastigmine—Erythema—Dapsone—leprosy	0.00321	0.00343	CcSEcCtD
Rivastigmine—Lymphadenopathy—Thalidomide—leprosy	0.0032	0.00342	CcSEcCtD
Rivastigmine—Thrombophlebitis—Thalidomide—leprosy	0.00316	0.00337	CcSEcCtD
Rivastigmine—Diabetes mellitus—Thalidomide—leprosy	0.00314	0.00335	CcSEcCtD
Rivastigmine—Blood alkaline phosphatase increased—Thalidomide—leprosy	0.00314	0.00335	CcSEcCtD
Rivastigmine—Gastroenteritis—Thalidomide—leprosy	0.00308	0.00329	CcSEcCtD
Rivastigmine—Deafness—Thalidomide—leprosy	0.00305	0.00326	CcSEcCtD
Rivastigmine—Vascular purpura—Thalidomide—leprosy	0.00305	0.00326	CcSEcCtD
Rivastigmine—Eczema—Thalidomide—leprosy	0.00304	0.00325	CcSEcCtD
Rivastigmine—Vision blurred—Dapsone—leprosy	0.00303	0.00323	CcSEcCtD
Rivastigmine—Eye pain—Thalidomide—leprosy	0.00303	0.00323	CcSEcCtD
Rivastigmine—Injury—Thalidomide—leprosy	0.00297	0.00317	CcSEcCtD
Rivastigmine—Renal failure acute—Thalidomide—leprosy	0.00296	0.00316	CcSEcCtD
Rivastigmine—Libido decreased—Thalidomide—leprosy	0.00295	0.00314	CcSEcCtD
Rivastigmine—Amnesia—Thalidomide—leprosy	0.00291	0.0031	CcSEcCtD
Rivastigmine—Increased appetite—Thalidomide—leprosy	0.00291	0.0031	CcSEcCtD
Rivastigmine—Vertigo—Dapsone—leprosy	0.00289	0.00308	CcSEcCtD
Rivastigmine—Atrial fibrillation—Thalidomide—leprosy	0.00288	0.00308	CcSEcCtD
Rivastigmine—Dermatitis bullous—Thalidomide—leprosy	0.00286	0.00305	CcSEcCtD
Rivastigmine—Purpura—Thalidomide—leprosy	0.00283	0.00303	CcSEcCtD
Rivastigmine—Arthritis—Thalidomide—leprosy	0.00281	0.003	CcSEcCtD
Rivastigmine—Cough—Dapsone—leprosy	0.0028	0.00299	CcSEcCtD
Rivastigmine—Cardiac failure—Thalidomide—leprosy	0.0028	0.00299	CcSEcCtD
Rivastigmine—Hypoglycaemia—Thalidomide—leprosy	0.0028	0.00299	CcSEcCtD
Rivastigmine—Cerebrovascular accident—Thalidomide—leprosy	0.00279	0.00298	CcSEcCtD
Rivastigmine—Hyponatraemia—Thalidomide—leprosy	0.00274	0.00293	CcSEcCtD
Rivastigmine—Pain in extremity—Thalidomide—leprosy	0.00273	0.00292	CcSEcCtD
Rivastigmine—Diplopia—Thalidomide—leprosy	0.00273	0.00292	CcSEcCtD
Rivastigmine—Osteoarthritis—Thalidomide—leprosy	0.00273	0.00292	CcSEcCtD
Rivastigmine—Gastrointestinal haemorrhage—Thalidomide—leprosy	0.00273	0.00292	CcSEcCtD
Rivastigmine—Disturbance in sexual arousal—Thalidomide—leprosy	0.00271	0.00289	CcSEcCtD
Rivastigmine—Migraine—Thalidomide—leprosy	0.00269	0.00287	CcSEcCtD
Rivastigmine—Affect lability—Thalidomide—leprosy	0.00269	0.00287	CcSEcCtD
Rivastigmine—Psychotic disorder—Thalidomide—leprosy	0.00267	0.00285	CcSEcCtD
Rivastigmine—Face oedema—Thalidomide—leprosy	0.00264	0.00282	CcSEcCtD
Rivastigmine—Cardiac arrest—Thalidomide—leprosy	0.0026	0.00277	CcSEcCtD
Rivastigmine—Mood swings—Thalidomide—leprosy	0.00259	0.00276	CcSEcCtD
Rivastigmine—Ataxia—Thalidomide—leprosy	0.00257	0.00274	CcSEcCtD
Rivastigmine—Tachycardia—Dapsone—leprosy	0.00256	0.00273	CcSEcCtD
Rivastigmine—Dehydration—Thalidomide—leprosy	0.00254	0.00271	CcSEcCtD
Rivastigmine—Liver function test abnormal—Thalidomide—leprosy	0.00252	0.00269	CcSEcCtD
Rivastigmine—Dry skin—Thalidomide—leprosy	0.0025	0.00267	CcSEcCtD
Rivastigmine—Orthostatic hypotension—Thalidomide—leprosy	0.0025	0.00266	CcSEcCtD
Rivastigmine—Hypokalaemia—Thalidomide—leprosy	0.00249	0.00265	CcSEcCtD
Rivastigmine—Breast disorder—Thalidomide—leprosy	0.00247	0.00264	CcSEcCtD
Rivastigmine—Cramp muscle—Thalidomide—leprosy	0.00246	0.00263	CcSEcCtD
Rivastigmine—Muscular weakness—Thalidomide—leprosy	0.00241	0.00257	CcSEcCtD
Rivastigmine—Insomnia—Dapsone—leprosy	0.00237	0.00253	CcSEcCtD
Rivastigmine—Dysphagia—Thalidomide—leprosy	0.00236	0.00252	CcSEcCtD
Rivastigmine—Bronchospasm—Thalidomide—leprosy	0.00232	0.00248	CcSEcCtD
Rivastigmine—Pancreatitis—Thalidomide—leprosy	0.00231	0.00247	CcSEcCtD
Rivastigmine—Angina pectoris—Thalidomide—leprosy	0.0023	0.00246	CcSEcCtD
Rivastigmine—Bronchitis—Thalidomide—leprosy	0.00227	0.00242	CcSEcCtD
Rivastigmine—Upper respiratory tract infection—Thalidomide—leprosy	0.00219	0.00234	CcSEcCtD
Rivastigmine—Pollakiuria—Thalidomide—leprosy	0.00218	0.00233	CcSEcCtD
Rivastigmine—Erectile dysfunction—Thalidomide—leprosy	0.00217	0.00232	CcSEcCtD
Rivastigmine—Photosensitivity reaction—Thalidomide—leprosy	0.00216	0.0023	CcSEcCtD
Rivastigmine—Weight increased—Thalidomide—leprosy	0.00215	0.00229	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Dapsone—leprosy	0.00214	0.00229	CcSEcCtD
Rivastigmine—Weight decreased—Thalidomide—leprosy	0.00214	0.00228	CcSEcCtD
Rivastigmine—Hyperglycaemia—Thalidomide—leprosy	0.00213	0.00227	CcSEcCtD
Rivastigmine—Pneumonia—Thalidomide—leprosy	0.00212	0.00226	CcSEcCtD
Rivastigmine—Infestation—Thalidomide—leprosy	0.00211	0.00225	CcSEcCtD
Rivastigmine—Drowsiness—Thalidomide—leprosy	0.00211	0.00225	CcSEcCtD
Rivastigmine—Infestation NOS—Thalidomide—leprosy	0.00211	0.00225	CcSEcCtD
Rivastigmine—Depression—Thalidomide—leprosy	0.0021	0.00224	CcSEcCtD
Rivastigmine—Stevens-Johnson syndrome—Thalidomide—leprosy	0.00209	0.00223	CcSEcCtD
Rivastigmine—Acute coronary syndrome—Thalidomide—leprosy	0.00208	0.00222	CcSEcCtD
Rivastigmine—Body temperature increased—Dapsone—leprosy	0.00207	0.00221	CcSEcCtD
Rivastigmine—Abdominal pain—Dapsone—leprosy	0.00207	0.00221	CcSEcCtD
Rivastigmine—Renal failure—Thalidomide—leprosy	0.00207	0.00221	CcSEcCtD
Rivastigmine—Neuropathy peripheral—Thalidomide—leprosy	0.00206	0.0022	CcSEcCtD
Rivastigmine—Myocardial infarction—Thalidomide—leprosy	0.00206	0.0022	CcSEcCtD
Rivastigmine—Conjunctivitis—Thalidomide—leprosy	0.00205	0.00218	CcSEcCtD
Rivastigmine—Sweating—Thalidomide—leprosy	0.00202	0.00215	CcSEcCtD
Rivastigmine—Haematuria—Thalidomide—leprosy	0.00201	0.00214	CcSEcCtD
Rivastigmine—Epistaxis—Thalidomide—leprosy	0.00199	0.00212	CcSEcCtD
Rivastigmine—Sinusitis—Thalidomide—leprosy	0.00198	0.00211	CcSEcCtD
Rivastigmine—Bradycardia—Thalidomide—leprosy	0.00192	0.00205	CcSEcCtD
Rivastigmine—Rhinitis—Thalidomide—leprosy	0.00189	0.00202	CcSEcCtD
Rivastigmine—Hepatitis—Thalidomide—leprosy	0.00189	0.00202	CcSEcCtD
Rivastigmine—Hypoaesthesia—Thalidomide—leprosy	0.00188	0.00201	CcSEcCtD
Rivastigmine—Pharyngitis—Thalidomide—leprosy	0.00188	0.002	CcSEcCtD
Rivastigmine—Urinary tract disorder—Thalidomide—leprosy	0.00187	0.00199	CcSEcCtD
Rivastigmine—Oedema peripheral—Thalidomide—leprosy	0.00186	0.00199	CcSEcCtD
Rivastigmine—Urethral disorder—Thalidomide—leprosy	0.00185	0.00198	CcSEcCtD
Rivastigmine—Visual impairment—Thalidomide—leprosy	0.00182	0.00194	CcSEcCtD
Rivastigmine—Erythema multiforme—Thalidomide—leprosy	0.00179	0.00191	CcSEcCtD
Rivastigmine—Eye disorder—Thalidomide—leprosy	0.00177	0.00189	CcSEcCtD
Rivastigmine—Tinnitus—Thalidomide—leprosy	0.00176	0.00188	CcSEcCtD
Rivastigmine—Cardiac disorder—Thalidomide—leprosy	0.00175	0.00187	CcSEcCtD
Rivastigmine—Angiopathy—Thalidomide—leprosy	0.00171	0.00183	CcSEcCtD
Rivastigmine—Mediastinal disorder—Thalidomide—leprosy	0.0017	0.00182	CcSEcCtD
Rivastigmine—Chills—Thalidomide—leprosy	0.0017	0.00181	CcSEcCtD
Rivastigmine—Arrhythmia—Thalidomide—leprosy	0.00169	0.0018	CcSEcCtD
Rivastigmine—Alopecia—Thalidomide—leprosy	0.00167	0.00178	CcSEcCtD
Rivastigmine—Vomiting—Dapsone—leprosy	0.00167	0.00178	CcSEcCtD
Rivastigmine—Mental disorder—Thalidomide—leprosy	0.00166	0.00177	CcSEcCtD
Rivastigmine—Malnutrition—Thalidomide—leprosy	0.00165	0.00176	CcSEcCtD
Rivastigmine—Headache—Dapsone—leprosy	0.00164	0.00175	CcSEcCtD
Rivastigmine—Flatulence—Thalidomide—leprosy	0.00162	0.00173	CcSEcCtD
Rivastigmine—Tension—Thalidomide—leprosy	0.00161	0.00172	CcSEcCtD
Rivastigmine—Dysgeusia—Thalidomide—leprosy	0.00161	0.00172	CcSEcCtD
Rivastigmine—Nervousness—Thalidomide—leprosy	0.0016	0.00171	CcSEcCtD
Rivastigmine—Back pain—Thalidomide—leprosy	0.00159	0.0017	CcSEcCtD
Rivastigmine—Muscle spasms—Thalidomide—leprosy	0.00158	0.00169	CcSEcCtD
Rivastigmine—Nausea—Dapsone—leprosy	0.00156	0.00166	CcSEcCtD
Rivastigmine—Vision blurred—Thalidomide—leprosy	0.00155	0.00166	CcSEcCtD
Rivastigmine—Tremor—Thalidomide—leprosy	0.00154	0.00165	CcSEcCtD
Rivastigmine—Ill-defined disorder—Thalidomide—leprosy	0.00153	0.00163	CcSEcCtD
Rivastigmine—Anaemia—Thalidomide—leprosy	0.00152	0.00162	CcSEcCtD
Rivastigmine—Agitation—Thalidomide—leprosy	0.00151	0.00161	CcSEcCtD
Rivastigmine—Malaise—Thalidomide—leprosy	0.00148	0.00158	CcSEcCtD
Rivastigmine—Vertigo—Thalidomide—leprosy	0.00148	0.00158	CcSEcCtD
Rivastigmine—Syncope—Thalidomide—leprosy	0.00148	0.00157	CcSEcCtD
Rivastigmine—Palpitations—Thalidomide—leprosy	0.00145	0.00155	CcSEcCtD
Rivastigmine—Loss of consciousness—Thalidomide—leprosy	0.00145	0.00154	CcSEcCtD
Rivastigmine—Cough—Thalidomide—leprosy	0.00144	0.00153	CcSEcCtD
Rivastigmine—Convulsion—Thalidomide—leprosy	0.00143	0.00152	CcSEcCtD
Rivastigmine—Hypertension—Thalidomide—leprosy	0.00142	0.00152	CcSEcCtD
Rivastigmine—Arthralgia—Thalidomide—leprosy	0.0014	0.0015	CcSEcCtD
Rivastigmine—Chest pain—Thalidomide—leprosy	0.0014	0.0015	CcSEcCtD
Rivastigmine—Myalgia—Thalidomide—leprosy	0.0014	0.0015	CcSEcCtD
Rivastigmine—Anxiety—Thalidomide—leprosy	0.0014	0.00149	CcSEcCtD
Rivastigmine—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.00139	0.00148	CcSEcCtD
Rivastigmine—Discomfort—Thalidomide—leprosy	0.00138	0.00148	CcSEcCtD
Rivastigmine—Dry mouth—Thalidomide—leprosy	0.00137	0.00146	CcSEcCtD
Rivastigmine—Confusional state—Thalidomide—leprosy	0.00135	0.00145	CcSEcCtD
Rivastigmine—Oedema—Thalidomide—leprosy	0.00134	0.00143	CcSEcCtD
Rivastigmine—Infection—Thalidomide—leprosy	0.00133	0.00142	CcSEcCtD
Rivastigmine—Shock—Thalidomide—leprosy	0.00132	0.00141	CcSEcCtD
Rivastigmine—Nervous system disorder—Thalidomide—leprosy	0.00132	0.00141	CcSEcCtD
Rivastigmine—Thrombocytopenia—Thalidomide—leprosy	0.00131	0.0014	CcSEcCtD
Rivastigmine—Tachycardia—Thalidomide—leprosy	0.00131	0.0014	CcSEcCtD
Rivastigmine—Skin disorder—Thalidomide—leprosy	0.0013	0.00139	CcSEcCtD
Rivastigmine—Hyperhidrosis—Thalidomide—leprosy	0.0013	0.00139	CcSEcCtD
Rivastigmine—Anorexia—Thalidomide—leprosy	0.00128	0.00137	CcSEcCtD
Rivastigmine—Hypotension—Thalidomide—leprosy	0.00125	0.00134	CcSEcCtD
Rivastigmine—Musculoskeletal discomfort—Thalidomide—leprosy	0.00122	0.00131	CcSEcCtD
Rivastigmine—Insomnia—Thalidomide—leprosy	0.00121	0.0013	CcSEcCtD
Rivastigmine—Paraesthesia—Thalidomide—leprosy	0.00121	0.00129	CcSEcCtD
Rivastigmine—Dyspnoea—Thalidomide—leprosy	0.0012	0.00128	CcSEcCtD
Rivastigmine—Somnolence—Thalidomide—leprosy	0.00119	0.00127	CcSEcCtD
Rivastigmine—Dyspepsia—Thalidomide—leprosy	0.00118	0.00126	CcSEcCtD
Rivastigmine—Decreased appetite—Thalidomide—leprosy	0.00117	0.00125	CcSEcCtD
Rivastigmine—Gastrointestinal disorder—Thalidomide—leprosy	0.00116	0.00124	CcSEcCtD
Rivastigmine—Fatigue—Thalidomide—leprosy	0.00116	0.00124	CcSEcCtD
Rivastigmine—Constipation—Thalidomide—leprosy	0.00115	0.00123	CcSEcCtD
Rivastigmine—Pain—Thalidomide—leprosy	0.00115	0.00123	CcSEcCtD
Rivastigmine—Feeling abnormal—Thalidomide—leprosy	0.00111	0.00118	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Thalidomide—leprosy	0.0011	0.00117	CcSEcCtD
Rivastigmine—Urticaria—Thalidomide—leprosy	0.00107	0.00114	CcSEcCtD
Rivastigmine—Abdominal pain—Thalidomide—leprosy	0.00106	0.00113	CcSEcCtD
Rivastigmine—Body temperature increased—Thalidomide—leprosy	0.00106	0.00113	CcSEcCtD
Rivastigmine—Hypersensitivity—Thalidomide—leprosy	0.000989	0.00106	CcSEcCtD
Rivastigmine—Asthenia—Thalidomide—leprosy	0.000963	0.00103	CcSEcCtD
Rivastigmine—Pruritus—Thalidomide—leprosy	0.00095	0.00101	CcSEcCtD
Rivastigmine—Diarrhoea—Thalidomide—leprosy	0.000919	0.000981	CcSEcCtD
Rivastigmine—Dizziness—Thalidomide—leprosy	0.000888	0.000948	CcSEcCtD
Rivastigmine—Vomiting—Thalidomide—leprosy	0.000854	0.000911	CcSEcCtD
Rivastigmine—Rash—Thalidomide—leprosy	0.000847	0.000904	CcSEcCtD
Rivastigmine—Dermatitis—Thalidomide—leprosy	0.000846	0.000903	CcSEcCtD
Rivastigmine—Headache—Thalidomide—leprosy	0.000841	0.000898	CcSEcCtD
Rivastigmine—Nausea—Thalidomide—leprosy	0.000798	0.000851	CcSEcCtD
